Pfizer
Pfizer opens R&D hub in US Cambridge
June 17, 2014Manufacturing and Production, Research and Development, Sales and Marketing Cambridge, Massachusetts, Pfizer, kit, manufacturing, research
Pfizer has open a new 280,000 sq.ft. R&D hub in Cambridge, Massachusetts which also serves to bring together 1,000 of …
New chief scientific officer for Pfizer
June 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Morris Birnbaum, Pfizer
Dr Morris Birnbaum has joined Pfizer as its chief scientific officer for cardiovascular and metabolic disease research. Based in Cambridge …
Pfizer admits AstraZeneca defeat
May 27, 2014Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, Pfizer, Read, buyout, merger
Pfizer has acknowledged that it will not make an offer for AstraZeneca following the firms’ failure to agree a price …
‘Stop Alzheimer’s testing on animals’
May 22, 2014Research and Development, Sales and Marketing AZ, Alzheimer's, Pfizer, humane, langley
Animals should not be used for Alzheimer’s research according to a new paper, because scientists should instead be looking at …
AstraZeneca rejects Pfizer’s ‘final offer’
May 19, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, R&D, UK, science, takeover
AstraZeneca has this morning rejected a new bid from Pfizer that could have seen the US giant pay £69 billion …
Science left behind in Pfizer-AstraZeneca saga
May 18, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, Wellcome Trust, science
With all the posturing, debates and endless comment on the commercial aspects of a $106 billion deal between Pfizer and …
Pfizer to submit breast cancer drug
May 18, 2014Research and Development, Sales and Marketing Pfizer, breast cancer, femara, palbociclib
Pfizer, currently in the middle of trying to acquire AstraZeneca for $106 billion, says it will soon submit its new …
AstraZeneca signs UK research deal
May 16, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, Pfizer
The UK’s Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) and AstraZeneca will join forces to help discover new …
Pfizer: ‘fewer scientists’ after merger
May 14, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, UK, Willetts, merger, takeover
Pfizer’s proposed takeover of AstraZeneca would result in there being fewer scientists from both companies in the UK than currently …
Pfizer grilled by MPs – but AZ revelations shock
May 14, 2014Medical Communications, Sales and Marketing AZ, Pfizer, committee, merger, takeover
The two chiefs of AstraZeneca and Pfizer went head-to-head with MPs yesterday fighting their own corners in what is an …
Valeant ‘substantially undervalues’ Allergan
May 13, 2014Sales and Marketing Allergan, Botox, Pfizer, Valeant, buyout, merger
Allergan’s board has issued a defiant, unanimous rejection of the multi-billion dollar takeover offer made public by Valeant last month. In …
Poll: UK opposed to Pfizer takeover bid of AZ
May 13, 2014Research and Development, Sales and Marketing AstraZeneca, Cameron, Pfizer, UK, buyout, merger, research
The UK’s largest union says a new poll shows that the vast majority of the British public are against Pfizer’s …
AZ ‘consulted first’ by UK government after Pfizer bid
May 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, George Osborne, Pfizer, Wellcome Trust, david cameron
UK prime minister David Cameron has rejected claims that his government is prioritising discussions with Pfizer over its proposed acquisition …
Pfizer signs universities deal
May 12, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, academics, rare diseases
Pfizer has signed a five-year research deal with several top British universities to hunt for new treatments for rare disease. …
Wellcome Trust slams Pfizer/AstraZeneca bid
May 9, 2014Medical Communications, Sales and Marketing GSK, Pfizer, Read, astrazenca, emms, merger, takeover
The UK’s largest and most respected medical research charity the Wellcome Trust has warned that Pfizer’s potential takeover of AstraZeneca …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
